Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies
Owais Gul,1 Saqib Gul,2 Abdul Aziz Godil3
1Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan; 2Department of Medicine, Hamdard University, Karachi, Pakistan; 3Department of Medicine, Jinnah Medical and Dental College, Karachi, Pakistan
We read with great interest the recently published article “Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia” by Guzel et al.1 The study results are vital in understanding the variations among the levels of posterior pituitary neurohormones in patients with acute schizophrenia and seem to be of great value for future therapeutic modifications of the disease.
View the original paper by Guzel and colleagues.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]